Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity

NCT07001904 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07001904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
November 1, 2023
Completion date
October 31, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease severity, interleukin-6, plaque psoriasis